Engineered E. coli Enhances Tumor Immunotherapy via NO
In a groundbreaking advancement at the intersection of microbiology and cancer immunotherapy, researchers have engineered a strain of Escherichia coli ...
In a groundbreaking advancement at the intersection of microbiology and cancer immunotherapy, researchers have engineered a strain of Escherichia coli ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine